These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

445 related items for PubMed ID: 17137182

  • 1. [Neuronal injury in multiple sclerosis].
    Correale J, Meli F, Ysrraelit C.
    Medicina (B Aires); 2006; 66(5):472-85. PubMed ID: 17137182
    [Abstract] [Full Text] [Related]

  • 2. Axonal and neuronal pathology in multiple sclerosis: what have we learnt from animal models.
    Lassmann H.
    Exp Neurol; 2010 Sep; 225(1):2-8. PubMed ID: 19840788
    [Abstract] [Full Text] [Related]

  • 3. Neurodegeneration in autoimmune CNS inflammation.
    Herz J, Zipp F, Siffrin V.
    Exp Neurol; 2010 Sep; 225(1):9-17. PubMed ID: 19961850
    [Abstract] [Full Text] [Related]

  • 4. Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease.
    Bjartmar C, Wujek JR, Trapp BD.
    J Neurol Sci; 2003 Feb 15; 206(2):165-71. PubMed ID: 12559505
    [Abstract] [Full Text] [Related]

  • 5. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F, van Walderveen M.
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct 29; 354(1390):1675-86. PubMed ID: 10603619
    [Abstract] [Full Text] [Related]

  • 6. Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat.
    Papadopoulos D, Pham-Dinh D, Reynolds R.
    Exp Neurol; 2006 Feb 29; 197(2):373-85. PubMed ID: 16337942
    [Abstract] [Full Text] [Related]

  • 7. Novel therapeutic targets for axonal degeneration in multiple sclerosis.
    Petratos S, Azari MF, Ozturk E, Papadopoulos R, Bernard CC.
    J Neuropathol Exp Neurol; 2010 Apr 29; 69(4):323-34. PubMed ID: 20448478
    [Abstract] [Full Text] [Related]

  • 8. Putting magnetic resonance spectroscopy studies in context: axonal damage and disability in multiple sclerosis.
    Matthews PM, De Stefano N, Narayanan S, Francis GS, Wolinsky JS, Antel JP, Arnold DL.
    Semin Neurol; 1998 Apr 29; 18(3):327-36. PubMed ID: 9817537
    [Abstract] [Full Text] [Related]

  • 9. Pathogenesis of axonal and neuronal damage in multiple sclerosis.
    Dutta R, Trapp BD.
    Neurology; 2007 May 29; 68(22 Suppl 3):S22-31; discussion S43-54. PubMed ID: 17548565
    [Abstract] [Full Text] [Related]

  • 10. Neurological disability correlates with spinal cord axonal loss and reduced N-acetyl aspartate in chronic multiple sclerosis patients.
    Bjartmar C, Kidd G, Mörk S, Rudick R, Trapp BD.
    Ann Neurol; 2000 Dec 29; 48(6):893-901. PubMed ID: 11117546
    [Abstract] [Full Text] [Related]

  • 11. Pathogenesis of brain and spinal cord atrophy in multiple sclerosis.
    Minagar A, Toledo EG, Alexander JS, Kelley RE.
    J Neuroimaging; 2004 Jul 29; 14(3 Suppl):5S-10S. PubMed ID: 15228754
    [Abstract] [Full Text] [Related]

  • 12. Beta-Interferon treatment does not always slow the progression of axonal injury in multiple sclerosis.
    Parry A, Corkill R, Blamire AM, Palace J, Narayanan S, Arnold D, Styles P, Matthews PM.
    J Neurol; 2003 Feb 29; 250(2):171-8. PubMed ID: 12574947
    [Abstract] [Full Text] [Related]

  • 13. [Axonal damage in multiple sclerosis].
    Arbizu-Urdiain T, Martínez-Yélamos A.
    Rev Neurol; 2003 Feb 29; 30(12):1223-7. PubMed ID: 10935255
    [Abstract] [Full Text] [Related]

  • 14. Astrocyte-associated axonal damage in pre-onset stages of experimental autoimmune encephalomyelitis.
    Wang D, Ayers MM, Catmull DV, Hazelwood LJ, Bernard CC, Orian JM.
    Glia; 2005 Aug 15; 51(3):235-40. PubMed ID: 15812814
    [Abstract] [Full Text] [Related]

  • 15. Macrophages and neurodegeneration.
    Hendriks JJ, Teunissen CE, de Vries HE, Dijkstra CD.
    Brain Res Brain Res Rev; 2005 Apr 15; 48(2):185-95. PubMed ID: 15850657
    [Abstract] [Full Text] [Related]

  • 16. High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord.
    DeBoy CA, Zhang J, Dike S, Shats I, Jones M, Reich DS, Mori S, Nguyen T, Rothstein B, Miller RH, Griffin JT, Kerr DA, Calabresi PA.
    Brain; 2007 Aug 15; 130(Pt 8):2199-210. PubMed ID: 17557778
    [Abstract] [Full Text] [Related]

  • 17. Gray matter involvement in multiple sclerosis.
    Pirko I, Lucchinetti CF, Sriram S, Bakshi R.
    Neurology; 2007 Feb 27; 68(9):634-42. PubMed ID: 17325269
    [Abstract] [Full Text] [Related]

  • 18. Inflammation and degeneration in multiple sclerosis.
    Brück W, Stadelmann C.
    Neurol Sci; 2003 Dec 27; 24 Suppl 5():S265-7. PubMed ID: 14652785
    [Abstract] [Full Text] [Related]

  • 19. Magnetic resonance imaging monitoring of multiple sclerosis lesion evolution.
    Inglese M, Grossman RI, Filippi M.
    J Neuroimaging; 2005 Dec 27; 15(4 Suppl):22S-29S. PubMed ID: 16385016
    [Abstract] [Full Text] [Related]

  • 20. Axonal loss and gray matter pathology as a direct result of autoimmunity to neurofilaments.
    Huizinga R, Gerritsen W, Heijmans N, Amor S.
    Neurobiol Dis; 2008 Dec 27; 32(3):461-70. PubMed ID: 18804534
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.